Macrogenics (MGNX) Change in Inventory (2021 - 2026)
Macrogenics (MGNX) posted quarterly Change in Inventory of $1.6 million for Q1 2026, down 83.14% year-over-year from $9.4 million in Q1 2025, and up 289.17% quarter-over-quarter from -$840000.0 in Q4 2025.
Powered by 
Analysis
Macrogenics (MGNX) Change in Inventory (2021 - 2026) Analysis & Trends
Macrogenics (MGNX) has reported Change in Inventory for 6 consecutive years, with $1.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory fell 83.14% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $73000.0 (down 99.37% YoY), while the FY2025 annual figure was $7.9 million, up 261.52% from the prior year.
- Change in Inventory improved to $1.6 million in Q1 2026 per MGNX's latest filing, from -$840000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $9.4 million in Q1 2025 and bottomed at -$840000.0 in Q4 2025.
- Historically, Change in Inventory has averaged $670705.9 across 5 years, with a median of $27000.0 in 2024.
- On a YoY basis, Change in Inventory climbed as much as 34811.11% in 2025 and fell as far as 609.09% in 2025.
- Macrogenics' Change in Inventory stood at $364000.0 in 2022, then plunged by 57.42% to $155000.0 in 2023, then advanced by 6.45% to $165000.0 in 2024, then slumped by 609.09% to -$840000.0 in 2025, then surged by 289.17% to $1.6 million in 2026.
- Business Quant data shows MGNX's Change in Inventory at $1.6 million in Q1 2026, -$840000.0 in Q4 2025, and -$525000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Macrogenics | 284.90 Mn | 171.00 Mn | - | -347,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -347,000.00 |
| Mar 31, 2026 | 1.59 Mn |
| Dec 31, 2025 | -840,000.00 |
| Sep 30, 2025 | -525,000.00 |
| Jun 30, 2025 | -151,000.00 |
| Mar 31, 2025 | 9.43 Mn |
| Dec 31, 2024 | 165,000.00 |
| Sep 30, 2024 | 2.13 Mn |
| Jun 30, 2024 | -133,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Dec 31, 2023 | 155,000.00 |
| Sep 30, 2023 | -377,000.00 |
| Jun 30, 2023 | 34,000.00 |
| Mar 31, 2023 | -42,000.00 |
| Dec 31, 2022 | 364,000.00 |
| Sep 30, 2022 | -57,000.00 |
| Jun 30, 2022 | -572,000.00 |
| Mar 31, 2022 | 210,000.00 |
| Dec 31, 2021 | 842,000.00 |
| Sep 30, 2021 | -894,000.00 |